GT Biopharma (GTBP) Stock Chart & Stock Price History $1.74 -0.18 (-9.11%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends GT Biopharma Stock Price Performance 5 Day Performance-33.14%1 Month Performance-42.97%3 Month Performance-14.88%6 Month Performance-40.24%Year-To-Date Performance-77.19%1 Year Performance-77.65% Receive GTBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now GTBP Stock Chart for Sunday, December, 22, 2024 GTBP Chart by TradingView GT Biopharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$1.92$1.75-9.11%$2.09$1.7286,166 shs$3.90 million12/19/2024$2.05$1.92-6.34%$2.19$1.8632,589 shs$4.29 million12/18/2024$2.61$2.05-21.46%$2.55$2.0582,296 shs$4.58 million12/17/2024$2.51$2.61+3.98%$2.71$2.4728,780 shs$5.83 million12/16/2024$2.75$2.51-8.73%$2.94$2.5018,972 shs$5.61 million12/13/2024$2.74$2.75+0.36%$3.18$2.7219,671 shs$6.14 million Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$2.80$2.74-2.14%$3.29$2.7446,202 shs$6.11 million12/11/2024$3.04$2.80-7.94%$3.39$2.8050,511 shs$6.24 million12/10/2024$2.72$3.04+11.82%$3.07$2.6927,046 shs$6.78 million12/09/2024$2.57$2.72+5.84%$2.72$2.585,518 shs$6.07 million12/06/2024$2.48$2.57+3.63%$2.59$2.4112,311 shs$5.73 million12/05/2024$2.74$2.48-9.49%$2.87$2.4140,489 shs$5.53 million12/04/2024$2.89$2.74-5.19%$2.89$2.6930,079 shs$6.11 million12/03/2024$2.79$2.89+3.58%$2.90$2.8019,451 shs$6.45 million12/02/2024$2.80$2.79-0.36%$3.08$2.6947,161 shs$6.22 million11/29/2024$2.86$2.80-2.10%$2.94$2.789,436 shs$6.24 million11/28/2024$2.86$2.86$3.01$2.866,875 shs$6.39 million11/27/2024$3.05$2.86-6.08%$3.01$2.866,875 shs$6.39 million11/26/2024$2.96$3.05+2.87%$3.15$2.9227,933 shs$6.79 million11/25/2024$3.06$2.96-3.27%$3.15$2.9514,544 shs$6.60 million11/22/2024$3.01$3.06+1.66%$3.15$2.8212,048 shs$6.84 million11/21/2024$3.19$3.01-5.64%$3.19$2.975,753 shs$6.71 million Related Companies MiNK Therapeutics Stock Price Chart Lisata Therapeutics Stock Price Chart Calidi Biotherapeutics Stock Price Chart Athira Pharma Stock Price Chart Mannatech Stock Price Chart GeoVax Labs Stock Price Chart iBio Stock Price Chart Pulmatrix Stock Price Chart NanoViricides Stock Price Chart IN8bio Stock Price Chart Receive GTBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GTBP) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GTBP Stock Alerts